- Stocks
- Healthcare
- NASDAQ: HQY

Price (delayed)

$82.35

Market cap

$6.34B

P/E Ratio

2,745

Dividend/share

N/A

EPS

$0.03

Enterprise value

$7.13B

HQY's revenue has surged by 84% year-on-year and by 3.1% since the previous quarter

The gross profit has surged by 67% year-on-year and by 2% since the previous quarter

HQY's net income has surged by 117% since the previous quarter but it has dropped by 94% year-on-year

HQY's EPS has surged by 110% since the previous quarter but it has dropped by 97% year-on-year

HQY's gross margin is down by 9% year-on-year

What are the main financial stats of HQY

Market
Valuations
Earnings

Shares outstanding

76.99M

Market cap

$6.34B

Enterprise value

$7.13B

Price to earnings (P/E)

2,745

Price to book (P/B)

4.67

Price to sales (P/S)

8.46

EV/EBIT

150.47

EV/EBITDA

44.73

EV/Sales

9.55

Revenue

$746.6M

EBIT

$47.4M

EBITDA

$159.45M

Free cash flow

$92.5M

Per share
Balance sheet
Liquidity

EPS

$0.03

Free cash flow per share

$1.21

Book value per share

$17.63

Revenue per share

$9.73

TBVPS

$7.22

Total assets

$2.66B

Total liabilities

$1.3B

Debt

$1.09B

Equity

$1.36B

Working capital

$244.67M

Debt to equity

0.81

Current ratio

2.62

Quick ratio

2.4

Net debt/EBITDA

4.97

Margins
Efficiency
Dividend

EBITDA margin

21.4%

Gross margin

57.3%

Net margin

0.4%

Operating margin

6.7%

Return on assets

0.1%

Return on equity

0.3%

Return on invested capital

3.6%

Return on capital employed

1.9%

Return on sales

6.3%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Healthequity stock price performed over time

Intraday

-1.48%

1 week

3.81%

1 month

-9.52%

1 year

8.78%

YTD

18.13%

QTD

18.13%

How have Healthequity's revenue and profit performed over time

Revenue

$746.6M

Gross profit

$428.1M

Operating income

$50.14M

Net income

$3.28M

Gross margin

57.3%

Net margin

0.4%

HQY's net income has surged by 117% since the previous quarter but it has dropped by 94% year-on-year

The net margin has surged by 115% since the previous quarter but it has dropped by 97% year-on-year

HQY's revenue has surged by 84% year-on-year and by 3.1% since the previous quarter

The gross profit has surged by 67% year-on-year and by 2% since the previous quarter

What is Healthequity's growth rate over time

What is Healthequity stock price valuation

P/E

2,745

P/B

4.67

P/S

8.46

EV/EBIT

150.47

EV/EBITDA

44.73

EV/Sales

9.55

HQY's EPS has surged by 110% since the previous quarter but it has dropped by 97% year-on-year

The stock's P/B is 37% below its 5-year quarterly average of 7.4 but 33% above its last 4 quarters average of 3.5

The equity has grown by 33% YoY

HQY's revenue has surged by 84% year-on-year and by 3.1% since the previous quarter

The stock's price to sales (P/S) is 34% more than its last 4 quarters average of 6.3 but 32% less than its 5-year quarterly average of 12.5

How efficient is Healthequity business performance

HQY's return on sales has surged by 200% since the previous quarter but it has dropped by 64% year-on-year

The ROE has soared by 117% from the previous quarter but it has plunged by 96% YoY

The ROA has soared by 113% from the previous quarter but it has plunged by 98% YoY

HQY's ROIC has shrunk by 76% YoY

What is HQY's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for HQY.

How did Healthequity financials performed over time

Healthequity's total assets is 104% higher than its total liabilities

HQY's quick ratio is up by 41% year-on-year and by 9% since the previous quarter

Healthequity's current ratio has increased by 37% YoY and by 5% QoQ

The debt is 19% smaller than the equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.